Gloria is a MD/PhD student at Case Western Reserve University and was recognized by Forbes 30 Under 30 Healthcare in 2017 for her work with Universities Allied for Essential Medicines (UAEM), a global group of university students and academics organizing for public control over medicine and its pricing.

Gloria was an early member of Universities Allied for Essential Medicines (UAEM) and founded a UAEM chapter at the University of Florida in 2005 and now fosters the chapter at Case Western. Gloria is a proud past-member of the UAEM Coordinating Committee, where she worked from 2006-2011, primarily on UAEM empowerment and neglected disease projects. She served on the UAEM North American Board from 2011 to 2017, serving as President from 2015-2017.

Gloria’s research focuses on infectious disease genetics and immunology, particularly H. pylori bacterial genes associated with development of stomach cancer. She graduated from the University of Florida in 2009 with degrees in neurobiology, political science and a minor in public health. From 2009 to 2010, she conducted research in the neuropathology of dengue hemorrhagic fever in Mexico as a Fulbright scholar. The following year, she completed a research internship at the NIH as an intramural training fellow at the National Institute of Allergy and Infectious Diseases, studying malaria drug resistance. She is a physician/scientist/activist supporting several health justice endeavors in the local Cleveland, Ohio community.

Sub-specialties: drug pricing, biomedical research and development pipeline, alternative mechanisms of biomedical research and development, access to medicines, university role in increasing access to medicines, federal funding and access to medicines, malaria immunology, vaccines, malaria genetics, malaria drug resistance, H. pylori (bacterial) genetics and its role in stomach cancer, infectious disease research